The company is expanding its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy in Europe.
Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today ...